{
  "pmcid": "PMC2859392",
  "pmid": "20338069",
  "title": "Effects of CYP2B6 G516T polymorphisms on plasma efavirenz and nevirapine levels when co-administered with rifampicin in HIV/TB co-infected Thai adults",
  "overall_score": 0.13763124267260235,
  "num_benchmarks": 4,
  "benchmarks": {
    "drug_annotations": {
      "score": 0.0,
      "total_samples": 0,
      "ground_truth_annotations": {
        "count": 2,
        "matched_count": 0,
        "unmatched_count": 2,
        "items": [
          {
            "matched": false,
            "annotation": {
              "Variant Annotation ID": 1448993666,
              "Variant/Haplotypes": "rs3745274",
              "Gene": "CYP2B6",
              "Drug(s)": "efavirenz",
              "PMID": 20338069,
              "Phenotype Category": "Efficacy",
              "Significance": "no",
              "Notes": "No significant difference in median CD4 T cell counts of each genotype at different time points was seen in efavirenz group (p = 0.818, 0.838, 0.783, 0.753 and 0.587 for baseline, weeks 12, 24, 36 and 48 of ART, respectively).",
              "Sentence": "Genotype TT is not associated with response to efavirenz in people with HIV Infections and Tuberculosis as compared to genotypes GG + GT.",
              "Alleles": "TT",
              "Specialty Population": null,
              "Metabolizer types": null,
              "isPlural": "Is",
              "Is/Is Not associated": "Not associated with",
              "Direction of effect": null,
              "PD/PK terms": "response to",
              "Multiple drugs And/or": null,
              "Population types": "in people with",
              "Population Phenotypes or diseases": "Disease:HIV infectious disease, Disease:Tuberculosis",
              "Multiple phenotypes or diseases And/or": "and",
              "Comparison Allele(s) or Genotype(s)": "GG + GT",
              "Comparison Metabolizer types": null,
              "PMID_norm": "20338069",
              "Variant Annotation ID_norm": "1448993666"
            }
          },
          {
            "matched": false,
            "annotation": {
              "Variant Annotation ID": 1184988061,
              "Variant/Haplotypes": "rs3745274",
              "Gene": "CYP2B6",
              "Drug(s)": "efavirenz",
              "PMID": 20338069,
              "Phenotype Category": "Metabolism/PK",
              "Significance": "yes",
              "Notes": "Association with significantly increased efavirenz plasma levels. Was significant at week 6, 12 of treatment and 1 month after rifampicin discontinuation.",
              "Sentence": "Genotype TT is associated with decreased metabolism of efavirenz in people with HIV Infections and Tuberculosis as compared to genotypes GG + GT.",
              "Alleles": "TT",
              "Specialty Population": null,
              "Metabolizer types": null,
              "isPlural": "Is",
              "Is/Is Not associated": "Associated with",
              "Direction of effect": "decreased",
              "PD/PK terms": "metabolism of",
              "Multiple drugs And/or": null,
              "Population types": "in people with",
              "Population Phenotypes or diseases": "Disease:HIV infectious disease, Disease:Tuberculosis",
              "Multiple phenotypes or diseases And/or": "and",
              "Comparison Allele(s) or Genotype(s)": "GG + GT",
              "Comparison Metabolizer types": null,
              "PMID_norm": "20338069",
              "Variant Annotation ID_norm": "1184988061"
            }
          }
        ]
      },
      "extra_predictions": {
        "count": 2,
        "items": [
          {
            "variant": "CYP2B6-G516T",
            "gene": "CYP2B6",
            "drug": "efavirenz, nevirapine",
            "annotation": {
              "Variant/Haplotypes": "CYP2B6-G516T",
              "Gene": "CYP2B6",
              "Drug(s)": "efavirenz, nevirapine",
              "Phenotype Category": "metabolism/PK",
              "Significance": "yes",
              "Notes": "Patients with TT genotype had significantly higher plasma efavirenz concentrations compared to GT and GG genotypes (p < 0.0001).",
              "Sentence": "Genotype TT is associated with increased plasma efavirenz concentrations in HIV/TB co-infected Thai adults.",
              "Alleles": "TT",
              "Metabolizer types": "poor metabolizer",
              "Comparison Allele(s) or Genotype(s)": "GT, GG",
              "Comparison Metabolizer types": "intermediate metabolizer",
              "Specialty Population": "",
              "Population types": "in people with HIV/TB co-infection",
              "Population Phenotypes or diseases": "Disease:HIV/TB co-infection",
              "isPlural": "Is",
              "Is/Is Not associated": "Associated with",
              "Direction of effect": "increased",
              "PD/PK terms": "concentrations of",
              "Multiple drugs And/or": "",
              "Multiple phenotypes or diseases And/or": "",
              "Citations": [
                "The mean 12-hour post-dose plasma efavirenz concentration in patients with TT genotype at weeks 6 and 12 of ART and 1 month after rifampicin discontinuation (10.97 \u00b1 2.32, 13.62 \u00b1 4.21 and 8.48 \u00b1 1.30 mg/L, respectively) were significantly higher than those with GT (3.43 \u00b1 0.29, 3.35 \u00b1 0.27 and 3.21 \u00b1 0.22 mg/L, respectively) (p < 0.0001) or GG genotypes (2.88 \u00b1 0.33, 2.45 \u00b1 0.26 and 2.08 \u00b1 0.16 mg/L, respectively) (p < 0.0001).",
                "This is the first report to demonstrate the effects of CYP2B6 G516T polymorphisms on plasma efavirenz and nevirapine concentrations when co-administered with rifampicin in HIV/TB co-infected Thai adults."
              ]
            }
          },
          {
            "variant": "CYP2B6-G516T",
            "gene": "CYP2B6",
            "drug": "efavirenz, nevirapine",
            "annotation": {
              "Variant/Haplotypes": "CYP2B6-G516T",
              "Gene": "CYP2B6",
              "Drug(s)": "efavirenz, nevirapine",
              "Phenotype Category": "metabolism/PK",
              "Significance": "yes",
              "Notes": "Plasma efavirenz concentrations were higher in patients with the TT genotype at all time points measured (weeks 6 and 12) compared to GT and GG genotypes.",
              "Sentence": "Genotype TT is associated with increased plasma nevirapine concentrations in HIV/TB co-infected Thai adults.",
              "Alleles": "TT",
              "Metabolizer types": "poor metabolizer",
              "Comparison Allele(s) or Genotype(s)": "GT, GG",
              "Comparison Metabolizer types": "intermediate metabolizer",
              "Specialty Population": "",
              "Population types": "in people with HIV/TB co-infection",
              "Population Phenotypes or diseases": "Disease:HIV/TB co-infection",
              "isPlural": "Is",
              "Is/Is Not associated": "Associated with",
              "Direction of effect": "increased",
              "PD/PK terms": "concentrations of",
              "Multiple drugs And/or": "",
              "Multiple phenotypes or diseases And/or": "",
              "Citations": [
                "The mean 12-hour post-dose plasma efavirenz concentration in patients with TT genotype at weeks 6 and 12 of ART... were significantly higher than those with GT... or GG genotypes (p < 0.0001).",
                "Likewise, the mean 12-hour post-dose plasma nevirapine concentration in patients carrying TT genotype at weeks 6 and 12 of ART... tended to be higher than those carrying GT... or GG genotypes (p = 0.003).",
                "This is the first report to demonstrate the effects of CYP2B6 G516T polymorphisms on plasma efavirenz and nevirapine concentrations when co-administered with rifampicin in HIV/TB co-infected Thai adults."
              ]
            }
          }
        ]
      }
    },
    "phenotype_annotations": {
      "score": 0.0,
      "total_samples": 0,
      "ground_truth_annotations": {
        "count": 0,
        "matched_count": 0,
        "unmatched_count": 0,
        "items": []
      },
      "extra_predictions": {
        "count": 0,
        "items": []
      }
    },
    "functional_analysis": {
      "score": 0.0,
      "total_samples": 0,
      "ground_truth_annotations": {
        "count": 0,
        "matched_count": 0,
        "unmatched_count": 0,
        "items": []
      },
      "extra_predictions": {
        "count": 0,
        "items": []
      }
    },
    "study_parameters": {
      "score": 0.6881562133630117,
      "total_samples": 2,
      "ground_truth_annotations": {
        "count": 2,
        "matched_count": 2,
        "unmatched_count": 0,
        "items": [
          {
            "matched": true,
            "overall_match_score": 0.6375730668797213,
            "annotation": {
              "Study Parameters ID": 1184988079,
              "Variant Annotation ID": 1184988061,
              "Study Type": "cohort",
              "Study Cases": 65.0,
              "Study Controls": null,
              "Characteristics": "HIV-1/TB co-infected receiving efavirenz-based ART and an anti-TB drug regimen.",
              "Characteristics Type": "Study Cohort",
              "Frequency In Cases": 0.62,
              "Allele Of Frequency In Cases": "G",
              "Frequency In Controls": null,
              "Allele Of Frequency In Controls": null,
              "P Value": "< 0.0001",
              "Ratio Stat Type": "OR",
              "Ratio Stat": null,
              "Confidence Interval Start": null,
              "Confidence Interval Stop": null,
              "Biogeographical Groups": "East Asian"
            },
            "field_comparison": {
              "Study Parameters ID": {
                "ground_truth": 1184988079,
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Variant Annotation ID": {
                "ground_truth": 1184988061,
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Study Type": {
                "ground_truth": "cohort",
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Study Cases": {
                "ground_truth": 65.0,
                "prediction": 65.0,
                "score": 1.0,
                "match_status": "match"
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Characteristics": {
                "ground_truth": "HIV-1/TB co-infected receiving efavirenz-based ART and an anti-TB drug regimen.",
                "prediction": "efavirenz group (CYP2B6-G516T genotypes)",
                "score": 0.9128793478012085,
                "match_status": "partial_match"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort",
                "score": 1.0,
                "match_status": "match"
              },
              "Frequency In Cases": {
                "ground_truth": 0.62,
                "prediction": 0.3846,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": "G",
                "prediction": "GG",
                "score": 0.9258627891540527,
                "match_status": "partial_match"
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "P Value": {
                "ground_truth": "< 0.0001",
                "prediction": "< 0.0001",
                "score": 1.0,
                "match_status": "match"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "Unknown",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Biogeographical Groups": {
                "ground_truth": "East Asian",
                "prediction": "Asian",
                "score": 0.0,
                "match_status": "no_match"
              }
            }
          },
          {
            "matched": true,
            "overall_match_score": 0.5768202508197111,
            "annotation": {
              "Study Parameters ID": 1448993668,
              "Variant Annotation ID": 1448993666,
              "Study Type": "cohort",
              "Study Cases": 65.0,
              "Study Controls": null,
              "Characteristics": "HIV-1/TB co-infected receiving efavirenz-based ART and an anti-TB drug regimen.",
              "Characteristics Type": "Study Cohort",
              "Frequency In Cases": 0.62,
              "Allele Of Frequency In Cases": "G",
              "Frequency In Controls": null,
              "Allele Of Frequency In Controls": null,
              "P Value": "> 0.05",
              "Ratio Stat Type": "OR",
              "Ratio Stat": null,
              "Confidence Interval Start": null,
              "Confidence Interval Stop": null,
              "Biogeographical Groups": "East Asian"
            },
            "field_comparison": {
              "Study Parameters ID": {
                "ground_truth": 1448993668,
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Variant Annotation ID": {
                "ground_truth": 1448993666,
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Study Type": {
                "ground_truth": "cohort",
                "prediction": null,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Study Cases": {
                "ground_truth": 65.0,
                "prediction": 65.0,
                "score": 1.0,
                "match_status": "match"
              },
              "Study Controls": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Characteristics": {
                "ground_truth": "HIV-1/TB co-infected receiving efavirenz-based ART and an anti-TB drug regimen.",
                "prediction": "efavirenz group (CYP2B6-G516T genotypes)",
                "score": 0.9128793478012085,
                "match_status": "partial_match"
              },
              "Characteristics Type": {
                "ground_truth": "Study Cohort",
                "prediction": "Study Cohort",
                "score": 1.0,
                "match_status": "match"
              },
              "Frequency In Cases": {
                "ground_truth": 0.62,
                "prediction": 0.4769,
                "score": 0.0,
                "match_status": "no_match"
              },
              "Allele Of Frequency In Cases": {
                "ground_truth": "G",
                "prediction": "GT",
                "score": 0.8930649161338806,
                "match_status": "partial_match"
              },
              "Frequency In Controls": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Allele Of Frequency In Controls": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "P Value": {
                "ground_truth": "> 0.05",
                "prediction": "< 0.0001",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Ratio Stat Type": {
                "ground_truth": "OR",
                "prediction": "Unknown",
                "score": 0.0,
                "match_status": "no_match"
              },
              "Ratio Stat": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Confidence Interval Start": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Confidence Interval Stop": {
                "ground_truth": null,
                "prediction": null,
                "score": 1.0,
                "match_status": "match"
              },
              "Biogeographical Groups": {
                "ground_truth": "East Asian",
                "prediction": "Asian",
                "score": 0.0,
                "match_status": "no_match"
              }
            }
          }
        ]
      },
      "extra_predictions": {
        "count": 7,
        "items": [
          {
            "variant": "N/A",
            "gene": "N/A",
            "drug": "N/A",
            "annotation": {
              "Study Parameters ID": null,
              "Variant Annotation ID": null,
              "Study Type": "cohort",
              "Study Cases": 124.0,
              "Study Controls": null,
              "Characteristics": "HIV/TB co-infected Thai adults receiving efavirenz or nevirapine",
              "Characteristics Type": "Study Cohort",
              "Frequency In Cases": null,
              "Allele Of Frequency In Cases": null,
              "Frequency In Controls": null,
              "Allele Of Frequency In Controls": null,
              "P Value": "< 0.0001",
              "Ratio Stat Type": "Unknown",
              "Ratio Stat": null,
              "Confidence Interval Start": null,
              "Confidence Interval Stop": null,
              "Biogeographical Groups": "Asian",
              "Variant Annotation ID_norm": null
            }
          },
          {
            "variant": "N/A",
            "gene": "N/A",
            "drug": "N/A",
            "annotation": {
              "Study Parameters ID": null,
              "Variant Annotation ID": null,
              "Study Type": null,
              "Study Cases": 65.0,
              "Study Controls": null,
              "Characteristics": "efavirenz group (CYP2B6-G516T genotypes)",
              "Characteristics Type": "Study Cohort",
              "Frequency In Cases": 0.1385,
              "Allele Of Frequency In Cases": "TT",
              "Frequency In Controls": null,
              "Allele Of Frequency In Controls": null,
              "P Value": "< 0.0001",
              "Ratio Stat Type": "Unknown",
              "Ratio Stat": null,
              "Confidence Interval Start": null,
              "Confidence Interval Stop": null,
              "Biogeographical Groups": "Asian",
              "Variant Annotation ID_norm": null
            }
          },
          {
            "variant": "N/A",
            "gene": "N/A",
            "drug": "N/A",
            "annotation": {
              "Study Parameters ID": null,
              "Variant Annotation ID": null,
              "Study Type": null,
              "Study Cases": 59.0,
              "Study Controls": null,
              "Characteristics": "nevirapine group (CYP2B6-G516T genotypes)",
              "Characteristics Type": "Study Cohort",
              "Frequency In Cases": 0.4407,
              "Allele Of Frequency In Cases": "GG",
              "Frequency In Controls": null,
              "Allele Of Frequency In Controls": null,
              "P Value": null,
              "Ratio Stat Type": "Unknown",
              "Ratio Stat": null,
              "Confidence Interval Start": null,
              "Confidence Interval Stop": null,
              "Biogeographical Groups": "Asian",
              "Variant Annotation ID_norm": null
            }
          },
          {
            "variant": "N/A",
            "gene": "N/A",
            "drug": "N/A",
            "annotation": {
              "Study Parameters ID": null,
              "Variant Annotation ID": null,
              "Study Type": null,
              "Study Cases": 59.0,
              "Study Controls": null,
              "Characteristics": "nevirapine group (CYP2B6-G516T genotypes)",
              "Characteristics Type": "Study Cohort",
              "Frequency In Cases": 0.5254,
              "Allele Of Frequency In Cases": "GT",
              "Frequency In Controls": null,
              "Allele Of Frequency In Controls": null,
              "P Value": null,
              "Ratio Stat Type": "Unknown",
              "Ratio Stat": null,
              "Confidence Interval Start": null,
              "Confidence Interval Stop": null,
              "Biogeographical Groups": "Asian",
              "Variant Annotation ID_norm": null
            }
          },
          {
            "variant": "N/A",
            "gene": "N/A",
            "drug": "N/A",
            "annotation": {
              "Study Parameters ID": null,
              "Variant Annotation ID": null,
              "Study Type": null,
              "Study Cases": 59.0,
              "Study Controls": null,
              "Characteristics": "nevirapine group (CYP2B6-G516T genotypes)",
              "Characteristics Type": "Study Cohort",
              "Frequency In Cases": 0.0339,
              "Allele Of Frequency In Cases": "TT",
              "Frequency In Controls": null,
              "Allele Of Frequency In Controls": null,
              "P Value": null,
              "Ratio Stat Type": "Unknown",
              "Ratio Stat": null,
              "Confidence Interval Start": null,
              "Confidence Interval Stop": null,
              "Biogeographical Groups": "Asian",
              "Variant Annotation ID_norm": null
            }
          },
          {
            "variant": "N/A",
            "gene": "N/A",
            "drug": "N/A",
            "annotation": {
              "Study Parameters ID": null,
              "Variant Annotation ID": null,
              "Study Type": null,
              "Study Cases": 124.0,
              "Study Controls": null,
              "Characteristics": "CYP2B6-TT genotype's impact on plasma efavirenz concentration",
              "Characteristics Type": "disease",
              "Frequency In Cases": null,
              "Allele Of Frequency In Cases": null,
              "Frequency In Controls": null,
              "Allele Of Frequency In Controls": null,
              "P Value": "= 0.025",
              "Ratio Stat Type": "Unknown",
              "Ratio Stat": null,
              "Confidence Interval Start": null,
              "Confidence Interval Stop": null,
              "Biogeographical Groups": "Asian",
              "Variant Annotation ID_norm": null
            }
          },
          {
            "variant": "N/A",
            "gene": "N/A",
            "drug": "N/A",
            "annotation": {
              "Study Parameters ID": null,
              "Variant Annotation ID": null,
              "Study Type": null,
              "Study Cases": 124.0,
              "Study Controls": null,
              "Characteristics": "CYP2B6-TT genotype's impact on plasma nevirapine concentration",
              "Characteristics Type": "disease",
              "Frequency In Cases": null,
              "Allele Of Frequency In Cases": null,
              "Frequency In Controls": null,
              "Allele Of Frequency In Controls": null,
              "P Value": "= 0.003",
              "Ratio Stat Type": "Unknown",
              "Ratio Stat": null,
              "Confidence Interval Start": null,
              "Confidence Interval Stop": null,
              "Biogeographical Groups": "Asian",
              "Variant Annotation ID_norm": null
            }
          }
        ]
      }
    }
  }
}